← Back to Clinical Trials
Recruiting NCT04991467

NCT04991467 A Multimodal Parent-focused Intervention for Vulnerable Populations in the Bronx

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04991467
Status Recruiting
Phase
Sponsor Albert Einstein College of Medicine
Condition Parenting
Study Type INTERVENTIONAL
Enrollment 390 participants
Start Date 2021-12-17
Primary Completion 2026-12

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
All Conditions
Interventions
CARE Program and Valera Application with care manager functionalityValera Application with care manager functionalityCARE Program

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 390 participants in total. It began in 2021-12-17 with a primary completion date of 2026-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

For caregivers in the Bronx, the pandemic has caused unprecedented psychological distress; in addition to combating social determinants of health (SDOH), these families now face greater financial insecurity and challenges related to their school-aged children. Furthermore, social distancing requirements and limited telehealth resources for Bronx families have posed greater barriers to healthcare. Such parental distress contributes to heightened risk of transgenerational cycles of psychological stress, trauma and maltreatment. The social and economic impacts of the COVID-19 pandemic have had significant consequences for family well-being, putting parents at higher risk of experiencing distress and potentially impairing their ability to provide supportive care to their children. Although children may be less susceptible to the most damaging physical consequences of COVID-19, there are growing concerns regarding the short-and long-term impacts of pandemic-related stressors on children. The marked upheaval of family life over an extended period may make children vulnerable to mental health consequences associated with the public health crisis and infection mitigation efforts. School and childcare closures, unstable financial circumstances, social isolation and lack of support have a disproportionate, cumulative impact on parents and may undermine their capacities to provide support for their children. Importantly, a large body of evidence suggests that parental stress during times of disasters induces psychopathologies in family members including children. Further, high anxiety and depressive symptoms in parents during the pandemic have been associated with higher child abuse potential, whereas greater parental support was associated with lower perceived stress and child abuse potential. In addition to psychological impacts, stress associated with caregiving can interfere with parents' ability to maintain their own health. This multimodal study addresses key strategies to mitigate the psychological and health impact of COVID-19 in parents.

Eligibility Criteria

Inclusion Criteria: * All participants will be primary caregivers who present with moderate level of stress by meeting a severity score of ≥ 14 on the Perceived Stress Scale (PSS) * Investigators will allow primary caregivers (e.g., grandmothers and aunts) as it is common in the patient population * Clinical cohorts will be active patients in the psychiatric and rheumatology clinics in Montefiore Medical Center (MMC) * Frontline health care providers will be those who are required to work on site at Montefiore Medical Center (MMC) Exclusion Criteria: * Serious psychiatric or substance use difficulty that, in the judgement of the PI, would preclude meaningful participation in a parent intervention * Active child abuse/maltreatment cases * Neurocognitive conditions that may prevent participants from accessing telehealth services * Primary language other than Spanish or English * Use of the Valera Health app or a smartphone health platform similar to the Valera app

Contact & Investigator

Central Contact

Maria Pondikos, BA

✉ maria.pondikos@einsteinmed.edu

📞 631-965-5095

Principal Investigator

Jonathan Alpert, MD

PRINCIPAL INVESTIGATOR

Albert Einstein College of Medicine

Frequently Asked Questions

Who can join the NCT04991467 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Parenting. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04991467 currently recruiting?

Yes, NCT04991467 is actively recruiting participants. Contact the research team at maria.pondikos@einsteinmed.edu for enrollment information.

Where is the NCT04991467 trial being conducted?

This trial is being conducted at The Bronx, United States.

Who is sponsoring the NCT04991467 clinical trial?

NCT04991467 is sponsored by Albert Einstein College of Medicine. The principal investigator is Jonathan Alpert, MD at Albert Einstein College of Medicine. The trial plans to enroll 390 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology